Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash flows from operating activities:
Net loss	$ (3,156,505)	$ (1,183,376)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization	202,747	90,591
Loss on disposal of asset	2,501
Bad debt expense	15,000
Inventory obsolescence	71,819	7,312
Share-based compensation	584,935	325,518
Noncash lease expense	57,688	30,572
Loss on equity method investment	379,633	99,135
Changes in operating assets and liabilities:
Accounts receivable	(563,034)	(245,550)
Accounts receivable - related party	(16,492)
Inventory	(194,956)	(37,953)
Prepaid and other assets	292,394	91,757
Accounts payable	491,220	9,071
Accounts payable - related parties	(103,970)	(136,997)
Accrued royalties and expenses	234,141	(70,654)
Accrued bonus and commissions	(409,599)	(241,030)
Net cash used in operating activities	(2,112,478)	(1,261,604)
Cash flows from investing activities:
Purchase of property and equipment	(44,697)	(4,391)
Proceeds from disposal of assets	345
Investment in equity securities	(250,000)	(600,000)
Net cash used in investing activities	(294,352)	(604,391)
Cash flows from financing activities:
Draw on line of credit		800,000
Pay off line of credit		(800,000)
Public offering net proceeds		28,939,257
Net settlement of equity-based awards	(102,931)
Distribution to noncontrolling interest member		(200,000)
Net cash flows provided by (used in) financing activities	(102,931)	28,739,257
Net increase (decrease) in cash	(2,509,761)	26,873,262
Cash, beginning of period	18,652,841	455,366
Cash, end of period	16,143,080	27,328,628
Cash paid during the period for:
Interest		711
Income taxes
Supplemental noncash investing and financing activities:
Common stock issued for asset acquisitions		$ 1,750,000